Bellevue Group »

Kiniksa Pharmaceuticals Intl P Ord Shs Cl A shares owned by Bellevue Group

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals Intl P Ord Shs Cl A (KNSA) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals Intl P Ord Shs Cl A held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals Intl P Ord Shs Cl A by Bellevue Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $160k 8.1k 19.78

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Revolution Medicines (RVMD)
Neurocrine Biosciences (NBIX)
Alnylam Pharmaceuticals (ALNY)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Agios Pharmaceuticals (AGIO)
Incyte Corporation (INCY)
Scholar Rock Hldg Corp (SRRK)
Akero Therapeutics (AKRO)
Immunocore Hldgs Ads (IMCR)

View all positions for Bellevue Group

Top funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A

Rubric Capital Management
Vanguard Group
Baker Bros. Advisors
Tang Capital Management
Fairmount Funds Management
Acadian Asset Management
D. E. Shaw & Co
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Millennium Management
Pictet Asset Management Holding SA
FMR
Connor, Clark & Lunn Investment Management
Qube Research & Technologies
Parkman Healthcare Partners

View all funds holding Kiniksa Pharmaceuticals Intl P Ord Shs Cl A